All Ryjunea Articles
-
282Latest Myopia NewsSydnexis Shares Latest STAR Trial Data at AAPOS 2026
March 23, 2026 DEL MAR, Calif. — At the 2026 American Association for Pediatric Ophthalmology and Strabismus (AAPOS) annual meeting, Sydnexis shared...
-
644Editor’s PerspectiveWhen the Data Say Yes but the FDA Says No
The recent FDA decision on SYD-101 has implications on the eye care industry. November 17, 2025 Ashley Wallace Tucker, OD, FAAO, FSLS...
-
1.3KLatest Myopia NewsSydnexis Partner Santen Wins U.K. Approval for Ryjunea to Slow Childhood Myopia
November 6, 2025 DEL MAR, Calif. — Sydnexis‘ partner Santen has announced that the U.K. Medicines and Healthcare products Regulatory Agency (MHRA)...
-
724Latest Myopia NewsFDA Delays Approval of Sydnexis’ SYD-101 for Myopia, Asking for More Evidence
October 24, 2025 DEL MAR, Calif. — The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to...
-
2.2KLatest Myopia NewsSydnexis Receives Positive Opinion in Europe for SYD-101
April 2, 2025 DEL MAR, Calif. — Sydnexis has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human...